drugset / Trial / NCT00857480

Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin

NCT00857480

Phase 1 Completed 12 enrolled Norgine
RandomizedCrossoverOpen-labelDiagnostic

Summary

A study in healthy volunteers to determine whether different drugs metabolised by the liver have any effects on how NRL972 is processed within the body.

Timeline

Start
2006-06
Primary completion
2006-08
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject FLUORESCEIN LISICOL Diagnostic / imaging agent 2 mg Intravenous
Subject Ursodeoxycholic Acid Small molecule 500 mg
Subject cloxacillin Other / unclassified 1 g

Indications